Eco Animal Health Group PLC Result of AGM & GM (2362R)
04 Marzo 2021 - 09:07AM
UK Regulatory
TIDMEAH
RNS Number : 2362R
Eco Animal Health Group PLC
04 March 2021
4 March 2021
ECO Animal Health Group plc ("the Company")
(AIM: EAH)
Result of Annual General Meeting and General Meeting
ECO Animal Health Group plc announces that at both its Annual
General Meeting and General Meeting held earlier today ("AGM" and
"GM" respectively), all resolutions proposed to the meetings were
duly passed on a poll.
At the AGM the total votes cast on each resolution were as
follows:
Resolution For % Against % Withheld
1 39,817,344 97.68 946,305 2.32 1,452
----------- ------ -------- ----- ---------
2 40,763,180 99.99 469 0.01 1,452
----------- ------ -------- ----- ---------
3 40,751,532 99.97 12,117 0.03 1,452
----------- ------ -------- ----- ---------
4 40,761,973 99.99 1,676 0.01 1,452
----------- ------ -------- ----- ---------
5 40,760,507 99.99 4,141 0.01 453
----------- ------ -------- ----- ---------
6 40,316,884 98.90 447,764 1.10 453
----------- ------ -------- ----- ---------
7 40,759,099 99.99 5,549 0.01 453
----------- ------ -------- ----- ---------
At the GM the total votes cast on each resolution were as
follows:
Resolution For % Against % Withheld
1 39,491,382 96.74 886,334 2.17 445,053
----------- ------ ---------- ----- ---------
2 36,701,055 89.90 3,676,661 9.01 445,053
----------- ------ ---------- ----- ---------
Contacts:
ECO Animal Health Group plc
Marc Loomes (CEO)
Christopher Wilks (CFO) 020 8447 8899
IFC Advisory
Graham Herring
Zach Cohen 020 3934 6630
N+1 Singer (Nominated Adviser & Joint
Broker)
Mark Taylor
Iqra Amin 020 7496 3000
Peel Hunt LLP (Joint Broker)
James Steel
Dr Christopher Golden 020 7418 8900
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the GROUP") researches,
develops and commercialises products for livestock. Our business
strategy is to generate shareholder value by achieving the maximum
sales potential from the existing product portfolio whilst
investing in Research and Development ("R&D") for new products,
particularly vaccines, and seeking to in-license new product
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ROMEASDLEESFEFA
(END) Dow Jones Newswires
March 04, 2021 10:07 ET (15:07 GMT)
Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024